NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
02 Januar 2024 - 1:05PM
Business Wire
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology
testing services company, today announced the company will
participate in the upcoming 42nd Annual J.P. Morgan Healthcare
Conference in San Francisco, California.
Members of NeoGenomics’ management team will deliver a
presentation followed by Q&A on Monday, January 8th at 5:15
p.m. PT/8:15 p.m. ET. A live and archived audio webcast of the
presentation will be available on the “News, Events, and Webcasts”
tab via the Investor Relations section of the Company’s website at
ir.neogenomics.com.
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and
information services, providing one of the most comprehensive
oncology-focused testing menus for physicians to help them diagnose
and treat cancer. The Company's Advanced Diagnostic Division also
serves pharmaceutical clients in clinical trials and drug
development.
Headquartered in Fort Myers, FL, NeoGenomics operates CAP
accredited and CLIA certified laboratories for full-service sample
processing in Fort Myers, Florida; Aliso Viejo and San Diego,
California; Research Triangle Park, North Carolina; and Houston,
Texas; and a CAP accredited full-service, sample-processing
laboratory in Cambridge, United Kingdom. NeoGenomics also has
several, small, non-processing laboratory locations across the
United States for providing analysis services. NeoGenomics serves
the needs of pathologists, oncologists, academic centers, hospital
systems, pharmaceutical firms, integrated service delivery
networks, and managed care organizations throughout the United
States, and pharmaceutical firms in Europe and Asia.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240102990844/en/
Investor Contact Kendra Sweeney
kendra.sweeney@neogenomics.com
Media Contact Lisa Whitmyer
lisa.whitmyer@neogenomics.com
NeoGenomics (NASDAQ:NEO)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
NeoGenomics (NASDAQ:NEO)
Historical Stock Chart
Von Jun 2023 bis Jun 2024